Antisense oligonucleotides targeting human protein kinase C-α inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells

Molecular Pharmacology

Volumn 51, Issue 2, 1997, Pages 209-216

  Levesque, Luc ^a   Dean, Nicholas M ^a   Sasmor, Henri ^a   Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BRADYKININ; BRADYKININ B2 RECEPTOR; CALCIUM ION; ISOENZYME; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL TYPE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME POLYMORPHISM; HUMAN; HUMAN CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION;

EID: 0031037550     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.2.209     Document Type: Article

References (40)

1. 2+ mobilization by neurotensin in NG108-15 cells. Eur. J. Pharmacol. 161:203-208 (1989).
2. Luo, S.-F., H.-L. Tsao, R. Ong, J.-T. Hsieh, and C. M. Wang. Inhibitory effect of phorbol ester on bradykinin-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells. Cell. Signal. 7:571-581 (1995).
3. Yang, C. M., R. Ong, Y.-C. Chen, J.-T. Hsieh, H.-L. Tsao, and C.-T. Tsai. Effect of phorbol ester on phosphoinositide hydrolysis and calcium mobilization induced by endothelin-1 in cultured canine tracheal smooth muscle cells. Cell Calcium 17:129-140 (1995).
4. Chen, C.-C., J. Chang, and W.-C. Chen. Role of protein kinase C subtypes -α and -δ in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes. Mol. Pharmacol. 39:39-47 (1995).
5. Hug, H., and T. F. Sarre. Protein kinase C isoenzymes: divergence in signal transduction. Biochem. J. 291:329-343 (1993).
6. Hannun, Y. A., and R. M. Bell. Aminoacridines: potent inhibitors of protein kinase C. J. Biol. Chem. 263:5124-5131 (1988).
7. Hannun, Y. A., R. J. Foglesong, and R. M. Bell. The adriamycin-iron (III) complex is a potent inhibitor of protein kinase C. J. Biol. Chem. 264:9960-9966 (1989).
8. ++ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:397-102 (1986).
9. Meyer, T., U. Regenass, D. Fabbro, E. Alteri, J. Rosel, M. Muller, G. Caravatti, and A. A. Mater. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int. J. Cancer 43:851-856 (1989).
10. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553 (1989).
11. Toullec, d, P. Pianetti, H. Coste, P. Bellevergure, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. The bisindolylmaleimide GF109203 X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266: 15771-15781 (1991).
12. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041 (1984).
13. 4 receptor desensitization in RBL-1 cells. Mol. Pharmacol. 33:537-542 (1988).
14. Dekker, L. V., R. H. Palmer, and P. J. Parker. The protein kinase C and protein kinase C related gene families. Curr. Opin. Struct. Biol. 5:396-402 (1995).
15. II, -ε, -ζ and -η. J. Biol. Chem. 268:20110-20115 (1993).
16. Murray, N. R., G. P. Baumgardner, D. J. Burns, and A. P. Fields. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation: evidence that βII protein kinase C is required for proliferation. J. Biol. Chem. 268:15847-15853 (1993).
17. Leli, U., P. J. Parker, and T. B. Shea. Intracellular delivery of protein kinase C-α or -ε isoform-specific antibodies promotes acquisition of a morphologically differentiated phenotype in neuroblastoma cells. FEBS Lett. 297:91-94 (1992).
18. +- and charbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Biochem. J. 297:407-413 (1994).
19. Balboa, M. A., B. L. Firestein, C. Godson, K. S. Bell, and P. A. Insel. Protein kinase C-α mediates phospholipase D activation by nucleotides and phorbol ester in Madin-Darby canine kidney cells. J. Biol. Chem. 269:10511-10516 (1994).
20. 2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes. Biochem. J. 290:477-482 (1993).
21. I overexpression. J. Biol. Chem. 267:9826-9830 (1992).
22. Dean, N. M., R. McKay, T. P. Condon, and C. F. Bennett. Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule-1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269:16416-16424 (1994).
23. Dean, N. M., and R. McKay. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 91:11762-11766 (1994).
24. McKay, R. A., L. L. Cummins, M. J. Graham, E. A. Lesnik, S. R. Owens, M. Winniman and N. M. Dean. Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C α by the incorporation of 2′-O-propyl modifications. Nucleic Acids Res. 24:411-417 (1996).
25. Dean, N., R. McKay, L. Miraglia, R. Howard, S. Cooper, J. Giddings, P. Nicklin, L. Meister, R. Ziel, T. Geiger, M. Muller, and D. Fabbro. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res. 56: 3499-3507 (1996).
26. Altmann, K.-H., N. M. Dean, D. Fabbro, S. M. Frier, T. Geiger, R. Häner, D. Hüsken, P. Martin, B. P. Monia, M. Müller, F. Natt, P. Nicklin, J. Phillips, U. Pieles, H. Sasmor, and H. E. Moser. Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals. Chima 50:168-176 (1996).
27. Lesnik, E. A., C. J. Guinosso, A. M. Kawasaki, H. Sasmor, M. Zounes, L. L. Cummins, D. J. Ecker, P. D. Cook, and S. M. Frier. Oligodeoxynucleotides containing 2′-O-modified adenosine: synthesis and effects on stability of DNA:RNA duplexes. Biochemistry 32:7832-7838 (1993).
28. 1) receptor characteristics in rat aortic smooth muscle cells. Am. J. Physiol. 261:H1927-H1936 (1991).
29. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
30. Hall, J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:131-190 (1992).
31. Hock, F. J., K. Wirth, U. Albus, W. Linz, H. J. Gehards, G. Wiemer, S. Henke, G. Breipohl, W. Konig, J. Knolle, and B. A. Scholkens. Hoe-140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:769-773 (1991).
32. 1 cells. Cancer Lett. 76:19-24 (1994).
33. Nigam, S., S. Muller, and B. Walzog. Effect of staurosporine on fMet-Leu-Phe-stimulated human neutrophils: dissociated release of inositol 1,4,5-trisphosphate, diacylglycerol and intracellular calcium. Biochim. Biophys. Acta 1135:301-308 (1992).
34. Borner, C., U. Eppenberger, R. Wyss, and D. Fabbro. Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters. Proc. Natl. Acad. Sci. USA 85:2110-2114 (1988).
35. Young, S., P. Parker, A. Ullrich, and S. Stabel. Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem. J.:775-779 (1987).
36. 1. Cell. Mol. Endocrinol. 4:59-68 (1990).
37. Mochly-Rosen, D., C. J. Henrich, L. Cheever, J. Khaner, and P. C. Simpson. A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Mol. Biol. Cell 1:693-706 (1990).
38. Dessev, G., C. Iovcheva, B. Tasheva, and R. Goldman. Protein kinase activity associated with the nuclear lamina. Proc. Natl. Acad. Sci. USA 85:2994-2998 (1988).
39. Leach, K. L., E. A. Powers, V. A. Ruff, S. Jaken, and S. Kaufmann. Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells. J. Cell Biol. 109:685-695 (1989).
40. Bennett, C. F., M.-Y. Chiang, H. Chan, and S. Grimm. Use of cationic lipids to enhance the biological activity of antisense oligonucleotides. J. Liposome Res. 3:85-102 (1993).